课题基金 / 基金详情

Chemical Studies toward Development of Nerve Cell Degeneration Repairing or Protecting Agent

Chemical Studies toward Development of Nerve Cell Degeneration Repairing or Protecting Agent
神经细胞变性修复或保护剂开发的化学研究
批准号:
09680582
负责人:
FUKUYAMA Yoshiyasu
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

FUKUYAMA Yoshiyasu的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This research project has been performed toward development of nerve cell degeneration repairing and/or protecting agent from novel neurotrophic natural products. The following results have been obtained.(1) An unprecedented macrocyclic vibsane-type diterpene bearing an endo-peroxide in the molecule and novel limonoids were isolated as new neurotrophic active substances from the leaves of Viburnum awabuki and the roots of Melia azedarach Linn ver. Japonica, respectively.(2) The first synthesis of plagiochin A, a 16-membered bis(bibenzyl) which is one of the potent neurotrophic natural products has been accomplished by an intramolecular Pd(O)-catalyzed Still-Kelly reaction. Another neurotrophic sesquiterpenes dimers, mastigophorenes A and B have been obtained by oxidative phenol coupling of (+)-herebertendiol, which was already synthesized by applying an intramolecular Heck reaction to the construction of the quaternary carbon center linked to the benzene ring. The extremely simple syntheses of neurotrophic active substnaces, americanol A and isoamericanol A which were isolated from Phytolacca americana have been performed by HRP-catalyzed oxidative dimerization of caffeic acid.(3) Plant tissue culture has been applied to produce americanol A and isoamericanol A in the callus of Phytolacca americana, but their formation has not been so far realized. The callus successfully induced from the seeds of Belamcanda chinensis is now subjected to study on the condition of liquid culture. We will continue working on the production and biotransformation of neurotrophic active substances by using the plant tissue culture.(4) Apotosis system in the cell culture of fetal rat cerebral hemisphere has been modified, and thereby we will be able to screen natural products which inhibit the apotosis of the nerve cell induced by beta-amyloid protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Yoshiyasu Fukuyama: "Synthetic Studies on Neurotrophic Isocuparane- Type Dimers, Mastigophorenes, Isolated from the Liverwort Mastigophora diclados" Phytomedcine. 3・Suppl.1. 250-252 (1997)
Yoshiyasu Fukuyama:“从地钱 Mastigophora diclados 中分离出的神经营养性异螟烷型二聚体的合成研究”Phytomedcine 3·Suppl.1 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroyuki Minami: "Xanthones and Benzophenone from Garcinia subelliptica." Phytochemistry. 49.6. 1783-1785 (1998)
Hiroyuki Minami:“来自亚椭圆形藤黄果的氧杂蒽酮和二苯甲酮。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshiyasu Fukuyama et al.: "Garsubellins, Polyisoprenylated Phlorogulcin Derivatives from Garcinia subelliptica." Phytochemistry. 49, (3). 853-857 (1998)
Yoshiyasu Fukuyama 等人:“Garsubellins,来自 Garcinia subelliptica 的聚异戊二烯化苯丙素衍生物”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
17
    Bioorganic Studies on Neurotrophic Natural Products
    • 批准号:
      22590029
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2010
    • 负责人:
      FUKUYAMA Yoshiyasu
    • 依托单位:
    Synthesis of the Selective Nuclear Receptor LXRa Agonist, Riccardins and Development of Anti-arteriosclerosis Drug
    • 批准号:
      18590113
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.56万
    • 财政年份:
      2006
    • 负责人:
      FUKUYAMA Yoshiyasu
    • 依托单位:
    Analysis of Target Molecular and Preparation of Molecular Probes for Neurotrophic Low-Molecular Natural Products
    Pharmaceutical Studies Aiming at Nerve Cell Degeneration Repairing and Protecting Agent
    • 批准号:
      12480175
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.25万
    • 财政年份:
      2000
    • 负责人:
      FUKUYAMA Yoshiyasu
    • 依托单位: